Beam Therapeutics (BEAM) announced the appointment of Sravan Emany as CFO, effective December 19, 2024. He most recently served as CFO and COO at Ironwood Pharmaceuticals (IRWD)
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BEAM:
- Beam Therapeutics Strengthens Board with Pharma Veteran
- Beam Therapeutics appoints Guindo to its board of directors
- Beam Therapeutics management to meet virtually with Cantor Fitzgerald
- Beam Therapeutics participates in a conference call with JPMorgan
- Beam Therapeutics upgraded to Outperform from Market Perform at Leerink